Thomas Heineman
Chief Tech/Sci/R&D Officer at ONCOLYTICS BIOTECH INC.
Net worth: 547 172 $ as of 2024-03-30
Profile
Thomas C Heineman is currently the Chief Medical Officer at Oncolytics Biotech, Inc. He previously worked as the Senior Director-Clinical Research & Development at GSK Plc from 2006 to 2016.
He also held the position of Associate Professor at Saint Louis University School of Medicine.
From 2018 to 2020, he served as the Vice President & Head-Clinical Development at Halozyme Therapeutics, Inc. Additionally, he was the SVP & Head-Clinical Development at Denovo Biopharma LLC in 2020.
From 2016 to 2020, he worked as the Vice President & Head-Clinical Development at Genocea Biosciences, Inc. Dr. Heineman holds graduate and doctorate degrees from The University of Chicago.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ONCOLYTICS BIOTECH INC.
0.68% | 2024-03-06 | 516,200 ( 0.68% ) | 547 172 $ | 2024-03-30 |
Thomas Heineman active positions
Companies | Position | Start |
---|---|---|
ONCOLYTICS BIOTECH INC. | Chief Tech/Sci/R&D Officer | 2020-07-31 |
Former positions of Thomas Heineman
Companies | Position | End |
---|---|---|
Denovo Biopharma LLC
Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 2020-06-30 |
GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 2019-12-31 |
HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
GSK PLC | Chief Tech/Sci/R&D Officer | 2016-07-31 |
Saint Louis University School of Medicine | Corporate Officer/Principal | - |
Training of Thomas Heineman
The University of Chicago | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
HALOZYME THERAPEUTICS, INC. | Health Technology |
ONCOLYTICS BIOTECH INC. | Health Technology |
GENOCEA BIOSCIENCES, INC. | Health Technology |
GSK PLC | Health Technology |
Private companies | 1 |
---|---|
Denovo Biopharma LLC
Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Thomas Heineman